BioSpectrum India Magazine


Buy Now @ ₹ 100.00 Preview
India was considered as an all time favoured detsination for clinical trials. Most of the outsourced studies are phase III studies where India has a diverse pool of patents . Indian Clinical Trials market and clinical trial service is expected to grow significantlu along with trends